Suppr超能文献

增殖性糖尿病视网膜病变患者25G玻璃体切割术后复发性玻璃体出血的危险因素

Risk Factors for Recurrent Vitreous Hemorrhage After 25-Gauge Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy.

作者信息

Bitra Jyotsna, Sureshkumar Haarisudhan, Eathara Abhijith V, Alahmadi Reem, Heiferman Michael J

机构信息

Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, IL, USA.

Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.

出版信息

J Vitreoretin Dis. 2025 Jul 8:24741264251351545. doi: 10.1177/24741264251351545.

Abstract

To report the incidence of and risk factors associated with recurrent vitreous hemorrhage (VH) in eyes that had 25-gauge pars plana vitrectomy (PPV) for proliferative diabetic retinopathy (PDR). This study included 220 eyes of 185 patients who were 21 years old or older and who had PPV for PDR and a minimum postoperative follow-up of 3 months. For patients who had bilateral PPV, data were gathered from both eyes. If surgery was performed in only 1 eye, data were collected from that eye alone. The incidence of recurrent VH was 34.5% (76 eyes). The VH was categorized as early in 46 eyes (60.5%), delayed in 8 eyes (10.5%), or late in 22 eyes (28.9%). Sixty-eight eyes (89.5%) had mild/moderate recurrent VH and 8 (10.5%) had severe recurrent VH. The mean preoperative fasting blood glucose level was 147.7 mg/dL in eyes without recurrent VH and 176.7 mg/dL in eyes with recurrent VH ( = .020). Younger age ( = .027) and higher diastolic blood pressure at the time of surgery ( = .005) also significantly affected recurrent VH. Younger age, preoperative fasting blood glucose levels, and diastolic blood pressure were significantly associated with recurrent VH after PPV in patients with PDR.

摘要

报告接受25G玻璃体切割术(PPV)治疗增生性糖尿病视网膜病变(PDR)的患眼中复发性玻璃体出血(VH)的发生率及相关危险因素。本研究纳入了185例年龄在21岁及以上、因PDR接受PPV且术后至少随访3个月的患者的220只眼。对于接受双侧PPV的患者,双眼均收集数据。若仅一只眼进行了手术,则仅收集该眼的数据。复发性VH的发生率为34.5%(76只眼)。VH被分类为早期46只眼(60.5%)、延迟性8只眼(10.5%)或晚期22只眼(28.9%)。68只眼(89.5%)发生轻度/中度复发性VH,8只眼(10.5%)发生重度复发性VH。无复发性VH的患眼术前空腹血糖平均水平为147. mg/dL,有复发性VH的患眼为176.7 mg/dL(P = 0.020)。年龄较轻(P = 0.027)以及手术时较高的舒张压(P = 0.005)也对复发性VH有显著影响。年龄较轻、术前空腹血糖水平及舒张压与PDR患者PPV术后复发性VH显著相关。

相似文献

3
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Cochrane Database Syst Rev. 2023 Mar 20;3(3):CD008721. doi: 10.1002/14651858.CD008721.pub3.
4
A Pilot Randomized Controlled Trial Evaluating Hemostasis With Fibrin Glue During Surgery for Proliferative Diabetic Retinopathy.
Am J Ophthalmol. 2025 Apr;272:117-125. doi: 10.1016/j.ajo.2025.01.016. Epub 2025 Jan 28.
5
Ocriplasmin for symptomatic vitreomacular adhesion.
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD011874. doi: 10.1002/14651858.CD011874.pub2.
7
Surgical interventions for bilateral congenital cataract in children aged two years and under.
Cochrane Database Syst Rev. 2022 Sep 15;9(9):CD003171. doi: 10.1002/14651858.CD003171.pub3.
8
Laser therapy for retinopathy in sickle cell disease.
Cochrane Database Syst Rev. 2015 Oct 9;2015(10):CD010790. doi: 10.1002/14651858.CD010790.pub2.
9
Risk of Progression of Nonproliferative to Proliferative Diabetic Retinopathy after Cataract Surgery.
Ophthalmology. 2025 Jul;132(7):817-822. doi: 10.1016/j.ophtha.2025.02.006. Epub 2025 Feb 15.
10
Laser therapy for retinopathy in sickle cell disease.
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.

本文引用的文献

1
Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review.
Life (Basel). 2023 Jun 9;13(6):1362. doi: 10.3390/life13061362.
2
Persistence of Poverty and its Impact on Surgical Care and Postoperative Outcomes.
Ann Surg. 2023 Sep 1;278(3):347-356. doi: 10.1097/SLA.0000000000005953. Epub 2023 Jun 15.
5
Impact of low health literacy on patients' health outcomes: a multicenter cohort study.
BMC Health Serv Res. 2022 Sep 12;22(1):1148. doi: 10.1186/s12913-022-08527-9.
6
Household Income as a Predictor for Surgical Outcomes and Opioid Use After Spine Surgery in the United States.
Global Spine J. 2023 Oct;13(8):2124-2134. doi: 10.1177/21925682211070823. Epub 2022 Jan 10.
7
Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths.
JAMA Ophthalmol. 2021 Jul 1;139(7):791-795. doi: 10.1001/jamaophthalmol.2021.1551.
10
Predictors of Lost to Follow-Up in Patients Being Treated for Proliferative Diabetic Retinopathy.
Am J Ophthalmol. 2020 Aug;216:18-27. doi: 10.1016/j.ajo.2020.03.023. Epub 2020 Mar 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验